Abstract:Elevated uric acid (UA) is a key risk factor for many disorders, including metabolic syndrome, gout and kidney stones. Despite frequent occurrence of these disorders, the genetic pathways influencing UA metabolism and the association with disease remain poorly understood. In humans, elevated UA levels resulted from the loss of the of the urate oxidase (Uro) gene around 15 million years ago. Therefore, we established a Drosophila melanogaster model with reduced expression of the orthologous Uro gene to study the pathogenesis arising from elevated UA. Reduced Uro expression in Drosophila resulted in elevated UA levels, accumulation of concretions in the excretory system, and shortening of lifespan when reared on diets containing high levels of yeast extract. Furthermore, high levels of dietary purines, but not protein or sugar, were sufficient to produce the same effects of shortened lifespan and concretion formation in the Drosophila model. The insulin-like signaling (ILS) pathway has been shown to respond to changes in nutrient status in several species. We observed that genetic suppression of ILS genes reduced both UA levels and concretion load in flies fed high levels of yeast extract. Further support for the role of the ILS pathway in modulating UA metabolism stems from a human candidate gene study identifying SNPs in the ILS genes AKT2 and FOXO3 being associated with serum UA levels or gout. Additionally, inhibition of the NADPH oxidase (NOX) gene rescued the reduced lifespan and concretion phenotypes in Uro knockdown flies. Thus, components of the ILS pathway and the downstream protein NOX represent potential therapeutic targets for treating UA associated pathologies, including gout and kidney stones, as well as extending human healthspan.Enzymatic purine degradation in humans ends with uric acid (UA). Multiple genetic and dietary factors raise UA levels above the norm, which is called hyperuricemia or hyperuricosuria when detected in the serum or urine, respectively. Clinical studies report a correlation between elevated UA and a plethora of chronic diseases including crystalopathies like UA kidney stones and gout, or metabolic and vascular disorders such as diabetes, obesity, and coronary artery disease. Here, we identified a regulatory role for the insulin-like signaling cascade affecting UA metabolism using a Drosophila melanogaster model. In the process we determined previously unrecognized potential drug targets to treat elevated UA levels and associated pathologies such as gout or UA kidney stones, with the potential additional benefit of extending human healthspan. Our work also establishes the fly as a model system to characterize the influence of genetic and dietary factors in gout or UA kidney stone development in a manner readily amenable for small-scale screening of drug interventions. The novelty of our findings, their broad impact, and relevance for multiple diseases opens up an important area of research to define mechanisms of UA accumulation.

Probable Potential Role of Urate Transporter Genes in the Development of Metabolic Disorders

A 'complexity' of urate transporters

[Uric Acid Metabolism, Uric Acid Transporters and Dysuricemia].

Function of Uric Acid Transporters and Their Inhibitors in Hyperuricaemia

Examining the Association of Rare Allelic Variants in Urate Transporters SLC22A11, SLC22A13, and SLC17A1 with Hyperuricemia and Gout

Genetic and Physiological Effects of Insulin on Human Urate Homeostasis

The Regulation Effect of GLUT9/SLC2A9 on Intrahepatic Uric Acid Level and Metabolic Associated Fatty Liver Disease

The Impact of Uric Acid on Human Health: Beyond Gout and Kidney Stones

ADVANCEMENTS IN UNDERSTANDING THE MOLECULAR MECHANISMS REGULATING URIC ACID METABOLISM IN THE INTESTINE

Multiple Membrane Transporters and Some Immune Regulatory Genes are Major Genetic Factors to Gout

A Study of Correlation Between Uric Acid Transporter Gene SLC16A9 Polymorphism and Hyperuricemia in Uyghur

The Role of Uric Acid in Human Health: Insights from the Uricase Gene

SLC2A9 rs16890979 reduces uric acid absorption by kidney organoids

Uric acid in health and disease: From physiological function to pathogenic mechanism

Association between SLC2A9 transporter gene variants and uric acid phenotypes in African American and white families

The Role of ABCG2 in the Pathogenesis of Primary Hyperuricemia and Gout—An Update

Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease

A conserved role of the insulin-like signaling pathway in diet-dependent uric acid pathologies in Drosophila melanogaster

High-Resolution Melting Analysis for the Rapid Detection of an Intronic Single Nucleotide Polymorphism in Slc22a12 in Male Patients with Primary Gout in China

Donor-derived Hypouricemia in Irrelevant Recipients Caused by Kidney Transplantation.

Causal impact of human blood metabolites and metabolic pathways on serum uric acid and gout: a mendelian randomization study